Bo-Cheng Huang

发表

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity

T. Cheng, S. Roffler, Ming-Yii Huang, 2021, Journal of Nanobiotechnology.

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity

T. Cheng, S. Roffler, Ming-Yii Huang, 2020, Journal of Nanobiotechnology.

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy

Long-Sen Chang, T. Cheng, Chih-Hung Chuang, 2021, Scientific Reports.

Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis.

Yeh-long Chen, Jaw-Yuan Wang, T. Cheng, 2022, Pharmacological research.

Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules.

T. Cheng, S. Roffler, Ming-Yii Huang, 2017, Analytical chemistry.

A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis

Jui‐I Chao, T. Cheng, S. Yuan, 2023, Inflammation and Regeneration.

Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies

T. Cheng, Chih-Hung Chuang, Yuan-Chin Hsieh, 2020, Chemical science.

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy

Wen-han Lee, Jaw-Yuan Wang, T. Cheng, 2019, PLoS biology.

Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein

T. Cheng, S. Yuan, Chiu-Min Cheng, 2019, Scientific Reports.

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies

Jaw-Yuan Wang, T. Cheng, H. Tsai, 2022, Journal of Nanobiotechnology.

Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein

T. Cheng, S. Yuan, Chiu-Min Cheng, 2019, Scientific Reports.

Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20)

I-Ju Chen, Yi-An Cheng, Huei-Jen Chen, 2023, Cancer Nanotechnology.

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy

H. Lai, T. Cheng, Ming-Yii Huang, 2021, Scientific Reports.

Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab.

Chih-Hung Chuang, Fang-Ming Chen, Kai-Wen Ho, 2024, International journal of biological macromolecules.